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Abstract Obesity is associated with functional lim-
itations in muscle performance and increased likeli-
hood of developing a functional disability such as
mobility, strength, postural and dynamic balance
limitations. The consensus is that obese individuals,
regardless of age, have a greater absolute maximum
muscle strength compared to non-obese persons,
suggesting that increased adiposity acts as a chronic
overload stimulus on the antigravity muscles (e.g.,
quadriceps and calf), thus increasing muscle size and
strength. However, when maximummuscular strength
is normalised to body mass, obese individuals appear
weaker. This relative weakness may be caused by
reduced mobility, neural adaptations and changes in
muscle morphology. Discrepancies in the literature
remain for maximal strength normalised to muscle
mass (muscle quality) and can potentially be explained
through accounting for the measurement protocol
contributing to muscle strength capacity that need to
be explored in more depth such as antagonist muscle
co-activation, muscle architecture, a criterion valid
measurement of muscle size and an accurate mea-
surement of physical activity levels. Current evidence
demonstrating the effect of obesity on muscle quality
is limited. These factors not being recorded in some of
the existing literature suggest a potential underesti-
mation of muscle force either in terms of absolute
force production or relative to muscle mass; thus the
true effect of obesity upon skeletal muscle size,
structure and function, including any interactions with
ageing effects, remains to be elucidated.
Keywords Ageing  Functional limitations 
Obesity  Muscle strength  Sarcopenic obesity
Introduction
The prevalence of obesity is a prominent public health
concern. Within the UK the proportion of clinically
obese adults has increased from 17.5 to 26.1 %
between 1996 and 2010 (National Centre for Social
Research 2011), and these figures are predicted to rise
to 47 % of all men and 36 % of all women by 2025
(Butland et al. 2007). The problemwith the rising level
of obesity is the associated increased risk in develop-
ing a variety of conditions, such as non-insulin
dependent diabetes mellitus (DM; Steppan et al.
2001), cardiovascular disease (Larsson et al. 1984),
coronary heart disease (Manson et al. 1990),
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hypertension (Manicardi et al. 1986), stroke (Song
et al. 2004) and cancer (Bianchini et al. 2002). In
addition to these co-morbidities, obesity has been
shown to have a negative impact on skeletal muscle
through adolescence (Blimkie et al. 1990; Maffiuletti
et al. 2008) to both young (Hulens et al. 2001;
Maffiuletti et al. 2007) and old adulthood (Zoico et al.
2004; Rolland et al. 2004).
Researchers have examined the effect obesity has
on maximal isotonic (Lafortuna et al. 2005), isometric
(Tomlinson et al. 2014a) and isokinetic (Blimkie et al.
1990; Maffiuletti et al. 2007; Hulens et al. 2001, 2002;
Delmonico et al. 2009; Hilton et al. 2008) strength in a
variety of age classifications ranging from adolescents
to the elderly. The majority of these studies with the
focus being predominantly in the lower limbs, agree
that absolute strength is higher in obese compared to
non-obese individuals, and the consensus between all
studies is that strength is lower in the loaded muscu-
lature when normalised to total body mass. The
implications for reduced strength relative to body
mass in the lower limbs are foremost relevant to an
older population, as these are normally affected by a
reduced functional capacity (e.g., difficulty walking,
stairs negotiation and rising from a chair or bed)
(LaRoche et al. 2011; Rolland et al. 2009; Maden-
Wilkinson et al. 2015) and an increased risk of joint
pathologies (e.g., knee and hip osteoarthritis) (Cooper
et al. 1998; Slemenda et al. 1998) initiated through low
muscle strength increasing joint loads (Mikesky et al.
2000) thus increasing the likelihood of developing
osteoarthritis and additionally aiding in the progres-
sion of the condition, and leading to a reduced quality
of life. Accompanying rising age and obesity is the
potential increase and effect intramuscular fat has
upon muscle mechanics, through lowering muscle
quality (Rahemi et al. 2015), however this has not been
confirmed in human in vivo research. Therefore,
understanding the adaptations of skeletal muscle of
individuals who are classified obese across all age
groups with specific focus on the elderly needs to be a
priority, owing to the combination of a demography of
increased prevalence of obesity supplemented with
increased life expectancy (Kirkwood 2008).
It is possible that lower relative strength in older
obese people when compared to their normal weight
counterparts (Tomlinson et al. 2014a) may partly be
modulated via a higher state of systemic inflammation
(Schrager et al. 2007), as fat deposits can act as
endocrine organ secreting various pro-inflammatory
cytokines. This hypothesis is supported through obe-
sity-related increases in pro-inflammatory cytokines,
specifically interleukin-6 (IL-6) and tumour necrosis
factor-alpha (TNF-a; Schrager et al. 2007). Cytokines
are in fact associated with lower muscle mass and
strength in the elderly (presumably through stimulat-
ing muscle protein catabolism and inhibiting muscle
protein synthesis) (Visser et al. 2002). These effects
may be compounded by impaired skeletal muscle
regeneration capacity in obese individuals as hypoth-
esised by Akhmedov and Berdeaux (2013). This has
yet to be confirmed in a human population, however
animal models have demonstrated an impaired regen-
erative capacity in obese and diabetic mice (Nguyen
et al. 2011) with the mechanism suggested as being
through compromised satellite cell function due to
lipid overload (Akhmedov and Berdeaux 2013). Yet,
the specific effect that chronically high levels of
adiposity combined with ageing-associated systemic
inflammation and impaired skeletal muscle regenera-
tive capacity may have upon skeletal muscle structure
and function is yet to be fully understood.
Therefore, the aim of this review was to examine
the known link between adiposity and skeletal muscle
force and power generation through adolescence, to
young adults and finally old age.
Does the extra loading of adiposity seen in obesity,
act as a training stimulus on skeletal muscle
throughout the ages?
Investigations into the effects of obesity on muscle
size and function have described the inter-link
between muscle torque and power to body mass,
where obese people elicited higher absolute maximum
voluntary contraction (MVC) torque and power than
normal-weight individuals (Blimkie et al. 1990;
Lafortuna et al. 2005; Hulens et al. 2001; Maffiuletti
et al. 2007, 2008; Abdelmoula et al. 2012). A rationale
for higher absolute MVC torque and power in obese
individuals is from the suggestion by Thoren et al.
(1973) that extra mass from high levels of fat mass
seen in obese individuals might elicit a positive
training stimulus on skeletal muscle (see Fig. 1). This
hypothesis was strengthened by Bosco et al. (1986)
who reported increases in muscle power in anti-
gravity muscles following 3 weeks of simulated
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hypergravity through the use of weighted vests. The
weighted vests (7–8 % body mass) utilised in this
study were worn frommorning until evening similar to
the excess (fat) mass an obese individual would carry
around daily. It is crucial to note that the duration of
this study does not replicate the length of time
adiposity acts as a loading stimulus to an obese
individual; in addition, all participants were healthy
normal weight individuals. This study nonetheless
provides a comparable stimulus to the loaded anti-
gravity musculature of the lower limbs faced by obese
individuals during daily activities for an acute period.
The causative explanations given by Bosco et al.
(1986) for the increase in performance were through
increased motor unit firing rate, additional recruitment
of motor units and the synchronisation of these motor
units. These specific neural adaptations are accepted to
occur in the initial phase of resistance training, with
hypertrophy becoming the dominant factor after
3–5 weeks (Moritani and deVries 1979). However,
due to the gradual and sustained increases in fat mass
that an obese individual would experience, the
adaptations to skeletal muscle of an obese individual
may differ from that of a healthy individual undertak-
ing loaded resistance exercise. Therefore, this elicits
the question that if individuals are obese for numerous
years, would this increase muscle strength in the lower
limbs through carrying higher inert mass (i.e., adipose
tissue) during daily activities?
The effect of obesity on muscle strength
and structure in adolescent individuals
By assessing both neural and muscular components of
force generating capacity, Blimkie et al. (1990) were
the first to extensively examine skeletal muscle
performance in obese and non-obese adolescent
males. The main observation from the Blimkie study
was lower quadriceps femoris muscle activation in
obese compared to non-obese adolescent males (85.1
vs. 95.2 %; 100 % = complete voluntary muscle
activation). The obese adolescents studied by Blimkie
et al. (1990) were outpatients at a children’s exercise
and nutrition centre, while the non-obese adolescents
were selected from a local secondary school. It is not
known whether the two cohorts were matched for
habitual physical activity levels. Any potential differ-
ences in physical activity may have explained some of
the variability in neuromuscular variables, such as
agonist muscle activation and antagonist muscle co-
activation (Martinez-Gomez et al. 2011; Moliner-
Urdiales et al. 2010; Ramsay et al. 1990), which may
have also confounded any potential difference in
strength between obese and non-obese boys (Blimkie
et al. 1990). Notwithstanding potential differences in
the habitual physical activity background of the study
participants, the data suggested that relative to their
non-obese counterparts, obese adolescents had poorer
neural activation capacity, likely leading to a reduc-
tion in the degree and/or pattern of muscle fibre
recruitment. Yet it has been shown in an adult
population that high levels of visceral adiposity is
associated with increased neural sympathetic drive
(Alvarez et al. 2002).
Interestingly in the Blimkie et al. (1990) study,
there were no between group (obese vs. non-obese)
differences in absolute isometric strength at a variety
of muscle lengths (20, 40, 60, 90 of knee
extension) or in isokinetic knee strength (30, 60, 120
and 180/s). These results differ from later work by
Fig. 1 Representative DEXA scans taken from Tomlinson
et al. (2014b) of a (i) young obese female versus young normal
weight female and (ii) old obese female versus old normal
weight female. Colour key: blue for bone, red for lean tissue,
yellow for adipose tissue. (Color figure online)
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Maffiuletti et al. (2008), who reported significantly
higher absolute voluntary isometric strength in the
obese adolescent at short muscle lengths (?25 % at
40 extension) and during isokinetic efforts (?16 %).
However, the strength in the design of the Maffi-
uletti et al. (2008) study in comparison to Blimkie
et al. (1990) was the control of physical activity in the
adolescent males, as the exclusion criteria stated that
no individual took part in rigorous physical activity
and undertook less than 2 h/week of recreational
physical activity. In other words, the fact that Maffi-
uletti et al. (2008) considered physical activity levels
but Blimkie et al. (1990) did not, may in turn account
for the disparity in the reported impact of obesity
between the two studies. This is due to previously
reported data demonstrating that vigorous levels of
physical activity can increase strength in the anti-
gravity muscles of the lower limb (Moliner-Urdiales
et al. 2010). However, Maffiuletti et al. (2008)
proposed that a rationale for significantly higher
strength at short muscle lengths in the obese adoles-
cent cohort could be their preferentially working at
shorter muscle lengths to avoid excessive stress during
an activity/sport or to avoid injury. Such a habitual
loading protocol would shift the length–tension rela-
tionship to the left, hence placing obese adolescents at
a disadvantage in daily activities involving a wider
range of movement (e.g., deep squatting, getting up
from a chair, walking fast, bending).
Similarly to Maffiuletti et al. (2008), others such as
Abdelmoula et al. (2012) reported higher absolute
maximum isometric knee extension torque (?24 % at
60 of extension) and lower MVC torque relative to
body mass (-25 %) in obese compared to non-obese
adolescent males. Interestingly, Abdelmoula et al.
(2012) reported higher MVC isometric torque nor-
malised to thigh lean mass (?17.9 %) and estimated
thigh muscle mass (?22.2 %). This differs from
reports by both Blimkie et al. (1990) and Maffiuletti
et al. (2008), who reported no significant differences in
MVC knee extension torque normalised to quadriceps
anatomical cross sectional area (ACSA) (Blimkie et al.
1990) or fat free mass (FFM; Maffiuletti et al. 2008).
The discrepancies within these studies may be due to
differences in the methodology in assessing thigh/
quadriceps muscle mass. Indeed the gold standard in
the assessment of muscle size is the physiological
cross-sectional area (PCSA) as it accounts for the
pennate architecture of the quadricep femoris muscle
group. However, Abdelmoula et al. (2012) attributed
the higher strength relative to estimated muscle mass
in their study sample, to higher agonist muscle
activation and lower antagonist muscle co-activation
in the obese adolescents. It is noteworthy that whilst
Abdelmoula et al. (2012) did measure muscle mass/
volume, this could not explain the higher force seen in
the obese. It is thus possible that higher muscle
activation is indeed a potential explanation but as this
was not measured, it remains unclear what explains
the higher force in their study. The higher force in the
Abdelmoula study may in fact also be due to a greater
proportion of faster fibre (Clark et al. 2011). This
proposal however is tempered by studies that show
there is no real difference in specific tension between
slow and fast fibres, and if present this would only
explain a small proportion of the difference seen
(Ballak et al. 2014). Interestingly, the obese adoles-
cents had lower habitual physical activity levels,
which one would normally expect to lead to a lowering
in muscle activation capacity (Martinez-Gomez et al.
2011). Indeed as reported earlier, Blimkie et al. (1990)
found muscle activation to be significantly lower in
obese adolescent boys. Abdelmoula et al. (2012) also
proposed that there could have been an increase in the
contribution from the synergistic muscles in obese
adolescent boys. Whether there may be an obesity-
induced alteration in muscle recruitment strategy in
young adolescents has yet to be demonstrated. How-
ever, it needs to be noted that there is a lack of research
examining the neural responses into maximal strength
capacity in adolescent obese individuals after control-
ling for physical activity levels. Further research
examining this variable need to investigate both
agonist activation using the interpolated twitch tech-
nique and antagonist co-activation using surface
electromyography to rule out potential differences
between obese and normal weight adolescent individ-
uals. In parallel, we would propose an alternative
rationale for the higher strength values relative to
estimated muscle mass in the Abdelmoula et al. study
(2012): the differences in the intrinsic properties of the
skeletal muscle of the two cohorts. In support of this
hypothesis, previous research demonstrates an
increase in fast twitch fibres in obese 26–62 year old
adults (Kriketos et al. 1997). The potential shift in fibre
type may be explained by the lower physical activity
levels of the obese creating an effect similar to what is
observed in a detraining model (Staron et al. 1991).
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Such an effect, however, has yet to be confirmed in an
obese adolescent population and in many ways, is
opposite to the idea of loading through fat acting as an
additional load.
In summary, the general consensus is that obese
adolescents exhibit lower relative strength to body
mass (see Table 1). Yet discrepancies exist when
examining the absolute strength of obese versus non-
obese adolescents and strength relative to muscle mass
(muscle quality). These differences between studies
may be attributed to variability in the methodology,
including the control of habitual physical activity
difference between participant groups, and/or the
methods utilised in the quantification of muscle size.
However, current evidence suggests that there is no
effect of obesity on muscle quality, but as noted above
methodological issues need to be resolved. Interest-
ingly, it has previously been reported that obese
adolescents have lower agonist voluntary muscle
activation. The implication of this is the potential to
underestimate the strength capabilities of obese ado-
lescents in studies not correcting for this variable. Yet,
no study to date has examined the effect of antagonist
co-activation has uponmaximal torque output in obese
versus non-obese adolescent individuals thus poten-
tially leading to further underestimating the quality of
the muscle exposed to obesity. Further research in
adolescents should focus on examining the variables
that affect strength production such as agonist muscle
activation, antagonist co-activation, PCSA and
moment arm length.
The effect of obesity on muscle strength
and structure in young and old adults
One of the first studies to investigate the effects of
obesity on muscle strength in an adult population was
conducted by Hulens et al. (2001). The authors found
that the obese females had significantly higher
Table 1 Summarises research conducted into the effect of obesity on muscle strength in adolescence (14–17 years old)
Studies Gender Samples (years) Muscle
group
Measures Findings
Blimkie et al. (1990) M 11 Obese (16.5)
10 Non-obese
(16.6)
Range 15–18
KE – IM KE MVC 90, 120, 140,
160
– IK KE MVC 30/s, 60/s, 120/s,
180/s
– Thigh CSA using CT scans
– MUA
– Bioelectrical impedance
– IM MVC all angles
p = ns
– IK MVC all speeds
p = ns
– IM/BM ; obese
– IM/CSA all angles
p = ns
– IK/CSA all angles
p = ns
– MUA ; obese
Maffiuletti et al.
(2008)
M 10 Obese (15.6)
10 Non-obese
(14.9)
Range 13–17
KE – IM KE MVC 40, 80
– IK KE MVC 180/s
– Bioelectrical impedance
– IM MVC 40 : obese
– IM 40/FFM p = ns
– IM MVC 80 p = ns
– IM 80/FFM p = ns
– IK MVC : obese
– IK/FFM p = ns
Abdelmoula et al.
(2012)
M 12 Obese (14.2)
10 Non-obese
(14.4)
Range 12–15
KE – IM KE MVC 60
– DEXA
– IM MVC : obese
– IM/BM ; obese
– IM/FFM p[ 0.05
– IM/LM thigh : obese
– IM/MM thigh : obese
M males, F females, KE knee extensor, IM isometric, IK isokinetic, CSA cross sectional area, MUA motor unit activation, BM body
mass, LM lean mass, MM muscle mass, FFM fat free mass
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isokinetic knee extension, trunk extension, flexion and
rotational torque than the lean individuals, whilst no
impact of obesity was found on handgrip strength
suggesting an obesity ‘advantage’ in terms of absolute
muscle strength for the loaded musculature. The mean
age of the obese cohort was 39 years spanning a large
age range (20–65 years), which may have confounded
any effect of obesity on skeletal muscle force, as
ageing is associated with a decrease in maximal
muscle force (Morse et al. 2004). The importance of
age classification and its effect on muscle strength is
demonstrated in a separate study, in which Hulens
et al. (2002) accounted for the confounding age factor
and reported that the older obese (41–65 years) had
significantly lower knee extension isokinetic MVC
torque than their younger obese counterparts (18–40
years).
Hulens et al. (2001) had in fact reported that the
loaded antigravity muscles of the knee extensors, back
extensors and oblique abdominals were stronger in the
obese compared to the lean women. Yet, when
normalised to FFM, maximum knee extensor strength
was significantly 6–7 % lower in the obese cohort. The
discrepancy regarding absolute MVC torque and
MVC torque normalised to FFM may be due to lower
agonist muscle activation (as seen in adolescents
Blimkie et al. 1990). Lower activation of motor units
during a maximal contraction would potentially lower
maximal strength generation resulting in both lower
absolute and normalised MVC. Other explanations for
the discrepancy of MVC torque relative to FFM could
be the use of FFM instead of muscle volume or PCSA
to accurately assess MVC torque relative to muscle
size, due to it demonstrating an accurate in vivo
representation of the maximum number of parallel-
aligned sarcomeres. Interestingly, Hulens et al. (2001)
reported no differences in handgrip strength between
obese and non-obese individuals opposite to his
findings on absolute knee extensor strength, suggest-
ing the additional body mass may act as a training
stimulus, i.e., overloading the anti-gravity muscles in a
similar way that performance has been shown to
increase with the use of a weighted vest (Bosco et al.
1984). Hulens et al. (2001) supported this finding by
demonstrating MVC torque relative to FFM during
knee flexion was 18–20 % lower in obese versus non-
obese individuals, while MVC knee extension torque
was only 6–7 % lower, which would suggest that the
additional fat mass is a larger training load for the
extensors than the flexors. This hypothesis is sup-
ported by resistance training being associated with an
increase in skeletal muscle specific tension (Erskine
et al. 2010).
Lafortuna et al. (2005) went further to examine
gender differences in body composition, muscle
strength and power output in 95 morbidly obese adults
(28 men and 67 women) aged 29 ± 7 years. Body
composition was analysed with bioelectrical impe-
dance, while muscle strength of both the upper and
lower limbs was assessed using isotonic gym equip-
ment (chest press and leg press) and power output
assessed by a standing vertical jump. The main
findings of the study by Lafortuna et al. (2005)
revealed that obese young men were significantly
stronger in both upper and lower limbs and more
powerful than the obese young women, and these
differences were attributed to greater FFM in the men
(77.7 vs. 52 kg), a result which was expected since
males tend to demonstrate this effect even in non-
obese young adult populations (Janssen et al. 2000).
Interestingly, when isotonic strength was normalised
to FFM, all differences disappeared between genders
in both the obese and normal weight participants. In
terms of lower limb power output normalised to FFM,
data showed obese males to have lower relative power
to FFM than their normal weight counterparts and in
addition it showed a strong though non-significant
trend for a gender effect (p = 0.059). This could be
caused by a change in the intrinsic properties of the
skeletal muscle of the lower limb, through a shift in
fibre type composition to slower twitch fibres. This
further supports the theorem that high body mass loads
the antigravity muscles similarly to resistance training,
thus causing a fast–slow transition in fibre type
composition (Staron et al. 1994). This is demonstrated
by a mean difference of 20 kg more inert body mass
seen in the obese males than the obese females (128 vs.
108 kg) acting as potential enhanced loading stimulus
during daily living activities. The isotonic upper body
strength measures reported in this study support this
hypothesis, as no differences were reported in upper
body strength between normal weight and obese
participants irrespective of gender, yet significant
strength differences were observed in the anti-gravity
muscles during the leg press efforts.
Maffiuletti et al. (2007) reported obese males to
have higher absolute torque at all angles and velocities
suggesting that, in an adult population, obese
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individuals do not appear to favourably work at a
specific muscle length, contrary to adolescents who
exhibit higher absolute strength at short muscle lengths
(Maffiuletti et al. 2008). These differences may be
explained through obese adolescents preferentially
working at shorter muscle lengths as a mechanism to
facilitate the accomplishment of habitual daily activi-
ties (e.g., shallow/small squats); however this needs
further investigation. At their optimal angle and peak
velocity obese individuals had 16 and 20 % higher
absolute isometric and isokinetic torque, respectively,
compared with their non-obese counterparts. Yet, when
normalising absolute strength to body mass, maximum
isometric and isokinetic knee extension joint torque
were respectively 34.5 and 32.5 % lower than in
normal-weight individuals similar to previous work in
an adult population (Hulens et al. 2001; Lafortuna et al.
2005). However, when both isometric and isokinetic
MVC torque were normalised to FFM, any significant
differences between cohorts disappeared. It should be
noted that the standardisation of MVC torque to total
FFM does not differentiate the quadriceps femoris
muscle group from other muscle groups, hence extra-
neous synergistic/antagonistic muscles to knee exten-
sion efforts would have confounded the authors’
concluding remarks. Furthermore, MVC joint torque
is influenced by additional factors such as voluntary
muscle activation capacity, antagonist muscle co-
activation and the tendon moment arm (Erskine et al.
2009), which were not considered in this study. To date
however, no study has accounted for these differences
within the current literature in an adult population when
comparing obese–non-obese.
Further research by Maffiuletti et al. (2005)
reported that obese individuals have inadequate pos-
tural stability when compared to lean persons. These
balance issues were improved after a few postural
stability-training sessions during a body weight
reduction programme. This finding has implications
for the prevention of falls, especially in obese elderly
individuals who are more at risk of falls and fractures
(Himes and Reynolds 2012). Interestingly, the major-
ity of studies investigating the effect of obesity on
muscle strength have focussed on the knee extensors.
Yet, as demonstrated by Maffiuletti et al. (2005), the
contribution of the plantar flexors during postural
stability (Onambele et al. 2006) suggests more work
should focus on this muscle group when examining the
effect of obesity on muscle function.
Hilton et al. (2008) was one of the primary
investigators to focus on the plantar flexors. Contrary
to the findings of Hulens et al. (2001, 2002), Lafortuna
et al. (2005) and Maffiuletti et al. (2007), Hilton et al.
(2008) reported that MVC torque and lower limb
power were lower in obese compared to non-obese
people, both in absolute terms and when power was
normalised to muscle volume. Importantly to note, is
that the sample size of this study was small (n = 6,
BMI = 36 ± 8 vs. n = 6, BMI 28 ± 6) and the obese
subjects in this study had DM and peripheral neu-
ropathy. DM is strongly associated with both obesity
(Mokdad et al. 2003), and peripheral neuropathy
(Young et al. 1993), which is characterised by nerve
damage, leading to reduced neural function, motor
dysfunction (Andersen et al. 1997) and reduced
strength (Andersen et al. 1996). The rationale for
lower muscle strength in the obese/peripheral neu-
ropathy cohort of the Hilton et al. (2008) study is likely
to be the result of DM-induced neuropathy negatively
affecting muscle force generation. Interestingly, indi-
viduals only classified obese with no signs of periph-
eral neuropathy have shown reduced neural function
as previously demonstrated by lower muscle activa-
tion in both obese versus lean adolescents (Blimkie
et al. 1990) and high adiposity versus normal adiposity
young adults aged between 18 and 49 years old
(Tomlinson et al. 2014a, b, c). Nevertheless more
research is necessary to confirm if this is also the case
in older adults, and to what degree ageing may impact
on any association between obesity and muscle-
strength. What is clear however, is that one link is
likely to be through increased TNF-a levels in both
obesity and insulin resistance (Hotamisligil et al.
1995) which has an apoptotic effect on skeletal muscle
tissue (Kewalramani et al. 2010) and would in that
manner, negatively impact on the function of the
muscle-tendon unit as a whole.
Our own research (Tomlinson et al. 2014a) reported
obese adult females (18–49 years old) to have signif-
icantly greater plantar flexor strength that their age
matched normal and underweight counterparts. This
study was the first to control for both antagonist co-
contraction and agonist muscle activation during
maximal isometric contraction in any age classifica-
tion. Further research in our group Tomlinson et al.
(2014b) also revealed lower maximal strength in an
obese adult female cohort when plantar flexion
strength was computed relative to gastrocnemius
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medialis muscle volume. However, after accounting
for both the physiological (antagonist co-contraction,
agonist muscle activation, PCSA and pennation angle)
and biomechanical (moment arm length) determinants
of maximal strength capability, all significant differ-
ences were removed between both BMI and adiposity
classification.
In addition to these findings both Lafortuna et al.
(2013) and our own investigations (Tomlinson et al.
2014c) report increasing BMI and adiposity to be
associated with increased skeletal muscle volume in a
young adult population (18–49 years old), thus explain-
ing a rise in isometric strength demonstrated in the
obese (Tomlinson et al. 2014b). Interestingly, Lafor-
tuna et al. (2013) revealed a similar observation as the
male obese cohort had greater muscle mass which may
be attributed to alterations in the relative levels of
cytokines and anabolic hormones (Tipton 2001).
In summary, an analysis of studies in an adult
population suggests that obese individuals have sig-
nificantly higher absolute strength, but lower strength
normalised to body mass in the antigravity muscles of
the lower limb (see Table 2). However, upper limb
strength data reveals no statistical difference between
obese and normal weight individuals. This suggests
that the loading brought about through higher inert
mass (increased adiposity) simulates a resistance-
training stimulus, but only specifically to the weight
bearing (i.e., antigravity) musculature. Interestingly,
when absolute strength measures are made relative to
FFM, all significant differences between obese and
non-obese cohorts are erased in the majority of cases.
However, the use of total body FFM (instead of using
PCSA) does not account for the pennate architecture
of the knee extensors or plantar flexors, thus poten-
tially confounding the statistical differences between
cohorts. Interestingly, the combined effect of obesity
coupled with the co-morbidities of DM highlights the
detrimental effect of high adipose tissue content in
terms of lowering absolute and relative strength
through motor dysfunction, and thus negatively
impacting on activities of daily living.
The interaction between age and obesity, and its
effect on skeletal muscle (sarcopenic obesity)
The age related loss of skeletal muscle mass and
function has been termed ‘‘sarcopenia’’ (Narici and
Maffulli 2010; Rosenberg 1997). Sarcopenia has been
shown to increase the risk of developing functional
limitations (e.g., walking and climbing stairs) and
physical disabilities as defined by the difficulty in
performing daily activities (e.g., shopping, household
chores and making meals) (Janssen et al. 2002).
Therefore, reversing, delaying, and/or preventing the
development of sarcopenia and maintaining functional
mobility is paramount to ensuring a good quality of
later life. There does not appear to be a single cause for
sarcopenia as it is linked with decreased physical
activity, chronic systemic inflammation and neuro-
pathic changes leading to motor neuron death and
denervation of muscle fibres (Campbell et al. 1973;
Degens 2010). However, the presence of obesity
coupled with sarcopenia has been shown to exacerbate
functional limitations, increasing the difficulty in
performing physical functions that require strength
(Rolland et al. 2009). Baumgartner et al. (2004)
defined the combination of these morbidities as
‘sarcopenic obesity’. Individuals were classified as
sarcopenic obese through having an appendicular
skeletal muscle mass index [skeletal muscle mass (kg)
7 stature2 (m2)] greater than two standard deviations
below that of a 20–30 years old young adult reference
group (Baumgartner et al. 1998), combined with a
body fat percentage above the 60th percentile (Baum-
gartner et al. 2004).
As discussed above, obesity independent from
sarcopenia, has been associated with difficulty in
performing daily physical functions such as lifting
heavy objects and stair negotiation. Individuals with
sarcopenic obesity have an even greater difficulty in
performing these daily physical functions (Rolland
et al. 2009). Rolland et al. (2009) compared self-
reported difficulties with physical functions (i.e.,
walking, climbing stairs and rising from a chair) in
1308 healthy women aged 75 years old or older. These
women were classified into one of four categories
(healthy body composition, purely sarcopenic, purely
obese and sarcopenic obese). The investigators
reported purely sarcopenic women had no increased
odds of having physical difficulties with the functional
movement assessed when compared to the healthy
body composition elderly females of the study.
However, the purely obese were reported to have
44–79 % higher probability of having difficulty with
the functional movements assessed, whilst the sar-
copenic obese had a 2.6 higher probability of difficulty
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Table 2 Summarises research conducted into the effect of obesity on muscle strength through young to old adulthood (18–80 years
old)
Studies Gender Samples (years) Muscle
groups
Measures Findings
Hulens et al.
(2001)
F 173 Obese (39.9)
80 Lean (39.7)
Range 20–65
– KE
– KF
– TE
– TF
–
Forearm
– IK KE MVC 60/s
– IK KF MVC 60/s
– TE 60/s
– TF 60/s
– Handgrip MVC
– Bioelectrical
impedance
– IK KE MVC 60/s : obese
– IK KF MVC 60/s p = ns
– TE 60/s : obese
– TF 60/s : obese
– Handgrip MVC p = ns
Hulens et al.
(2002)
F 241 Obese (39.2)
Range 18–65
Two groups
Y = 18–40
O = 41–65
– KE
– KF
– TE
– TF
– IK KE MVC 60/s,
240/s
– IK KF MVC 60/s,
240/s
– TE 60/s, 120/s
– TF 60/s, 120/s
– Bioelectrical
impedance
– Baeke physical activity
questionnaire
– Y obese : IK KE MVC 60/s,
240/s
– Y obese : IK KF MVC 60/s,
240/s
– Y obese : TE 60/s, 120/s
– Y obese : TF 60/s, 120/s
Lafortuna et al.
(2005)
M and
F
28 M Obese (29.2)
8 M NW (30.8)
67 F obese (29.4)
10 F NW (30.0)
– Upper
limb
– Lower
limbs
– CP IT MVC
– LP IS MVC
– M : IT CP MVC
– M : IT LP MVC
– Obese versus NW IT CP MVC
p = ns (both M and F)
– M obese : IT LP MVC
– F obese : IT LP MVC
– M obese versus NW IT LP/FFM
p = ns
– F obese versus NW IT LP/FFM
p = ns
Maffiuletti
et al. (2007)
M 10 Obese (25.3)
10 Lean (27.0)
– KE – IM KE MVC 40, 60,
80
– IK KE MVC 60/s,
120/s, 180/s
– Bioelectrical
impedance
– Obese : IM MVC 40, 60, 80
– Obese : IK MVC 60/s, 120/s,
180/s
– Obese : IM MVC/BM 40, 60,
80
– Obese : IK MVC/BM 60/s, 120/
s, 180/s
– IM MVC/FFM 40, 60, 80
p = ns
– IK MVC/FFM 60/s, 120/s, 180/
s
Hilton et al.
(2008)
M and
F
6 Obese (58.0: 4 men, 2
women)
6 Overweight (58.0: 4
men, 2 women)
– PF
– DF
– PF and DF IM MVC 0
(neutral)
– PF and DF IK MVC
60/s, 120/s
– MV (PF DF muscle
group) using MRI
– IMAT
– ; Obese PF and DF IM MVC 0
– ; Obese PF and DF IK MVC 60/
s, 120/s
– Muscle volume p = ns
– Obese : IMAT
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Table 2 continued
Studies Gender Samples (years) Muscle
groups
Measures Findings
Lafortuna et al.
(2013)
M and
F
21 M (50.5, range
31–71)
18 F (55.0, range 32–76)
– Lower
limb
– Lower limb MV using
CT
– M MV versus adiposity
r2 = 0.683; p\ 0.001
– F MV versus adiposity
r2 = 0.214; p = 0.05
Tomlinson
et al. (2014a)
F 54 Y (26.7)
48 O (65.1)
18 Y Obese (30.9)
11 O Obese (62.5)
13 Y Normal (23.2)
15 O Normal (63.5)
– PF
– DF
– PF and DF IM MVC 0
– Co-contraction (using
sEMG)
– MUA
– DEXA
– : Y obese PF and DF IM MVC 0
– O PF and DF IM MVC 0 p = ns
– Y co-contraction p = ns
– O co-contraction p = ns
– Y MUA categorised by BMI
p = ns
– ; Y MUA categorised by body
fat % p = ns
– O MUA categorised by BMI
p = ns
– O MUA categorised by body
fat % p = ns
Tomlinson
et al. (2014b)
F 49 Y (25.5)
45 O (64.8)
16 Y Obese
11 O Obese
12 Y Normal
14 O Normal
– PF – GM IM PF MVC/MV
– GM specific force
– ; Y obese GM IM PF MVC/MV
– Y GM specific force p = ns
– O GM GM IM PF MVC/MV
p = ns
– O GM specific force p = ns
Tomlinson
et al. (2014c)
F 52 Y (25.0)
48 O (65.1)
17 Y Obese (30.9)
11 O Obese (62.5)
13 Y Normal (23.2)
15 O Normal (63.5)
– PF – GM MV
– GM PCSA
– GM Lf
– GM pennation angle
– : Y obese GM MV
– : Y obese GM PCSA
– Y GM Lf p = ns
– : Y obese GM pennation angle
– O GM MV p = ns
– O GM PCSA p = ns
– O GM Lf p = ns
– : O obese GM pennation angle
Zoico et al.
(2004)
F 167 F (range 67–78)
– NW
– Overweight
– Obese
– KE – KE IM MVC – KE IM MVC p = ns
Rolland et al.
(2004)
F 215 Obese (80.0)
630 NW (80.2)
598 Lean (80.7)
– EE
– KE
– EE IM MVC
– KE IM MVC
– Physical activity screen
– Obese : EE IM MVC (both NW
and lean)
– EE IM MVC p = ns (corrected for
PA)
– Obese : KE IM MVC 90 versus
lean
– Sedentary KE IM MVC p = ns
– Active obese : KE IM MVC 90
M males, F females, NW normal weight, KE knee extensor, KF knee flexion, IM isometric, IK isokinetic, IT isotonic, CSA cross
sectional area, MUA motor unit activation, BM body mass, LM lean mass, MM muscle mass, FFM fat free mass, TE trunk extension,
TF trunk flexion, Y young, O old, CP chest press, LP leg press, IMAT intra muscular adipose tissue, MRI magnetic resonance
imagery, CT computed tomography, MV muscle volume, sEMG surface electromyography, GM gastrocnemius medialis, PCSA
physiological cross sectional area, Lf fascicle length, PA physical activity
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in climbing stairs and 2.35 higher probability of
difficulty in going down stairs. Thus, it can be derived
from Rolland and colleagues’ study (2009) that
sarcopenia and obesity, have synergistic effects when
it comes to specific functional movements.
This research was supported by Zoico et al. (2004)
who reported older obese women to have a three–four
times increased risk of developing functional limita-
tions, where their BMI was higher than 30. However
within this study, individuals who had class II
sarcopenia (i.e., skeletal muscle mass index 2 standard
deviations below a young adult reference group
Janssen et al. 2002) had a similar risk of functional
limitations as the females who were only characterised
as obese. This research suggests that both conditions
play a role in limiting physical performance during
daily tasks. Potentially also, sarcopenia and obesity
may interact, intensifying the unfavourable conse-
quences of the two morbidities. A rationale for the
exacerbation of sarcopenia brought about by obesity
may be the increased mechanical stress to the
musculo-skeletal system through carrying the inert
mass of high levels of adipose tissue evident in
obesity. In addition, adipose tissue is known to act as
Fig. 2 Interplay between
obesity, inflammation and
skeletal muscle. Solid
arrows denote events with
established evidence. CRP
C-reactive protein, HGF
hepatocyte growth factor,
IL-1b interleukin-1b, IL-6
interleukin-6, IL-8
interleukin-8, IL-10
interleukin-10, IL-1Ra
interleukin-1 receptor
antagonist, MCP-1,
monocyte chemoattractant
protein 1, MIF macrophage
migration inhibitory factor,
NGF nerve growth factor,
PGE2 prostaglandin E2,
SAA 1 and 2 serum amyloid
A proteins 1 and 2, SV
stromovascular, TGF-b1
transforming growth factor-
b1, TNF-a tumor necrosis
factor-a, VEGF vascular
endothelial growth factor,
IGF-1 insulin-like growth
factor-1
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an endocrine organ, secreting numerous hormones and
inflammatory cytokines (Ahima and Flier 2000),
hence enhancing biochemical stress. Obese individu-
als store chronically high levels of adipose tissue,
which causes an increase in circulating pro-inflam-
matory cytokines (Hotamisligil et al. 1995). Pro-
inflammatory cytokines, such as TNF-a (Hotamisligil
et al. 1995), IL-1a (Juge-Aubry et al. 2003), IL-6 (Park
et al. 2005) and C-reactive protein (CRP) (Park et al.
2005) play a role in cell signalling in the response to
both acute and chronic systemic inflammation and can
have a detrimental impact on skeletal muscle by
stimulating muscle protein degradation (Garcia-Mar-
tinez et al. 1993) causing muscle wasting/atrophy and
reducing muscle protein synthesis (Mercier et al.
2002). The initiation of muscle wasting/atrophy is
modulated via numerous mechanisms such as activa-
tion of the ubiquitin–proteasome pathway (Cao et al.
2005; Degens 2010; Saini et al. 2006), which has been
shown to be effected via TNF-a (Llovera et al. 1998).
Chronically high levels of TNF-a initiates protein
degradation and decreased protein synthesis (Mercier
et al. 2002), with the net effect being skeletal muscle
atrophy (see Fig. 2).
The decrease in protein synthesis can also be related
to a reduction in anabolic hormones that would other-
wise promote the repair and regeneration of skeletal
muscle. This is observed in the reduction in insulin-like
growth factor-1 (IGF-1), a promoter of protein synthesis
andmuscle hypertrophy (DeVol et al. 1990), as reported
in severely obese women (Galli et al. 2012). Notably
within said study, IGF-1 levels following a surgical
intervention (laparoscopic adjustable gastric banding),
increased proportionately to the extent of weight loss.
This therefore demonstrates that lowering adiposity can
improve an individual’s anabolic profile. The inhibition
of IGF-1 is thought to be initiated by the TNF-a-
mediated activation of Jun N-terminal kinase (JNK)
(Grounds et al. 2008). Activation of JNK has also been
shown to play a role in the development of insulin
resistance andmetabolic syndrome throughdiet induced
obesity (Sabio et al. 2010). The overall implications of
low IGF-1 levels coupled with elevated pro-inflamma-
tory cytokines in an obese individual would be a
blunting of any beneficial effect of enhanced loading.
Such an effect may be further exacerbated in an elderly
population owing to a less than optimal endocrine
milieu normally associatedwith normal ageing: i.e., low
IGF-1, growth hormone and testosterone (Bucci et al.
2013; Lamberts et al. 1997) levels, combined with
higher fat infiltrationwithin skeletalmuscle (Delmonico
et al. 2009) and the ‘inflamed ageing’ phenomenon, i.e.,
higher circulatory levels of pro-inflammatory cytokines
(Visser et al. 2002).
In the literature on the effects of obesity on muscle
function in an elderly population, Rolland et al. (2004)
examined upper and lower limb muscle strength in
obese elderly women and how the effect of habitual
physical activity levels contributed to any differences
in maximum muscle strength between active/non-
active obese elderly individuals. The study consisted
of three cohorts: (i) obese (n = 215, BMI = 31.9), (ii)
normal weight (n = 630, BMI = 26.3), (iii) lean
(n = 598, BMI = 21.6) participants (it should be
noted that participants ought here to have been
categorised as obese, overweight and normal weight
individuals, to be more correct on the terminology).
Physical activity was controlled for and defined as
being active by taking part in at least one recreational
physical activity (i.e., hiking, swimming and garden-
ing) for greater than 1 h/week. The obese individuals
were shown to be less physically active than both the
lean and normal weight cohorts, yet when classifying
participants as either sedentary or active, obese
individuals with high activity levels demonstrated
higher absolute isometric knee extension strength
when compared to lean individuals. However, when
individuals were classed as sedentary, any significant
differences between cohorts were eradicated in rela-
tion to knee extension strength. Interestingly, there
was no difference in handgrip or elbow extension
strength between cohorts even though obese individ-
uals had significantly larger arm muscle mass when
compared to categorised normal weight and lean
individuals (Rolland et al. 2004). This may be
explained by the hypothesis presented earlier regard-
ing elevated adiposity causing additional overloading
of the anti-gravity muscles (e.g., quadriceps, triceps
surae) during routine daily activities, e.g., walking,
climbing steps, etc. This creates an environment of
hypergravity, which has been shown to increase
isokinetic plantar flexor strength by 40 % in post-
menopausal women following 12 weeks of resistance
training using weighted vests (Klentrou et al. 2007).
This benefit of weighted exercise has also been shown
in women aged between 50 and 75 years, who saw
increases in muscle strength, power and lean leg mass
after a 9-month training regime (Shaw and Snow 1998).
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In addition to these variables, the participants’ postural
stability was improved in the medio-lateral direction.
This specific improvement in postural balance has
been shown to benefit elderly frail individuals, as most
falls occur in a medio-lateral plane (Greenspan et al.
1998). Contrary to this beneficial effect of weighted
exercise, obese individuals are shown to have poor
postural stability (Maffiuletti et al. 2005). Thus, whilst
comparisons may be made between the additional
loading of a hypergravity environment against the
excess loading experienced by an obese individual
(through their own body mass), the detrimental
consequences of obesity appear to outweigh any
potential benefits of increased loading. However, as
shown by Rolland and colleagues (2004), increasing
physical activity levels may potentiate an increase in
muscle strength thereby lessening the detrimental
consequences of obesity. Interestingly in support of
this idea, our own work (Tomlinson et al. 2014a)
reveals that after controlling for physical activity
levels, no differences in raw plantar flexor muscle
strength exist between obese versus normal elderly
females aged between 50 and 80 years old, when
strength is corrected for antagonist co-contraction and
agonist muscle activation.
Villareal et al. (2004) looked into the association
between physical frailty and body composition in
obese elderly (n = 52), non-obese frail elderly
(n = 52) and non-obese non-frail elderly (n = 52).
The classification of physical frailty was defined using
three specific tests: a modified physical performance
test (PPT) consisting of 7 standardised timed tasks
(such as a 50 feet walk, putting on and removing a
coat, standing up from a 16 inch chair 5 times and
climbing a flight of stairs), Peak aerobic power (VO2
peak) using a graded treadmill test and a log of their
activities during daily living. From these three tests,
physical frailty was then defined if participants met
two out of three of the following criteria: modified
PPT score of between 18 and 32, VO2 peak of
11–18 mL/Kg/min and difficulty in performing two
daily activities (Villareal et al. 2004). Within the study
it was reported that the obese elderly individuals had
greater absolute FFM than both non-obese frail and
non-obese non-frail cohorts, yet when normalised to
total body mass it was found to be lower. In addition,
the obese individuals had poorer muscle quality, i.e.,
lower knee extension strength relative to leg lean
mass, compared to their non-obese counterparts. A
limitation of this assertion is that dual energy x-ray
absorptiometry (DEXA), as opposed to magnetic
resonance imagery (MRI) or ultrasound, cannot
differentiate between muscle groups. This is impor-
tant, due to the potential error in relating the torque
produced to whole leg lean mass instead of the muscle
group undertaking the specific task.
Delmonico et al. (2009) examined the effects of
sarcopenic obesity on muscle strength and physical
function. They reported an age-related increase in
intramuscular fat content at mid-thigh in both men and
women. Due to this being a longitudinal study it was
reported that after 5 years, intramuscular fat content
increased irrespective of changes in body mass and
subcutaneous fat in the thigh. Coupled with the increase
in intramuscular fat, the data showed that the loss of
knee extensor strength was two–five times greater than
the loss of mid-femur muscle cross sectional area with
ageing (Delmonico et al. 2009). The higher reported
decrease in strength may have partly been explained by
lower muscle activation and/or an increase in co-
activation, which was not accounted for when measur-
ing maximal strength. This study demonstrates that the
loading effect seen in younger individuals does not
attenuate the age-related loss of strength. The dispro-
portionate loss of strength versus muscle mass was
suggested through a loss in muscle quality, which has
previously been reported by both Morse et al. (2005)
and Goodpaster et al. (2006) in an elderly cohort. These
studies suggest that the rate of force loss with ageing is
similar in both obese and non-obese persons. It would
not be unreasonable to expect the positive association
between recreational physical activity and lower limb
strength in elderly obese individuals (Rolland et al.
2004) to offset a decrease in muscle quality.
In summary, with the increase in life expectancy
and the rise in obesity, it is unsurprising that
sarcopenic obesity incidence is also increasing (James
2008). Whilst the body of information regarding the
effects of sarcopenic obesity on skeletal muscle
structure and function is increasing, there remain gaps
in our knowledge. In contrast, ageing has been
associated with lower agonist muscle activation
(Morse et al. 2004), an increase in antagonist muscle
co-activation (Klein et al. 2001), a decrease in muscle
fascicle pennation angle (Morse et al. 2005) and lower
muscle volume (Thom et al. 2005). To-date, these
adaptations have not been systematically examined in
a sarcopenic obese elderly population. However,
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community dwelling obese adult females have shown
similar characteristics when compared to a young
adult obese female population (Tomlinson et al.
2014a, b, c), obesity was shown to exacerbate the
age-related physical function limitations associated
with the loss of muscle mass and strength.
Conclusion
Obesity is recognised as being a worldwide epidemic
and a major public health concern (James 2008). It has
been reported to have detrimental implications for the
functioning of skeletal muscle yet very little is known
about the specific adaptations of skeletal muscle by
gender and age, in the presence of chronically elevated
adiposity.
The consensus within the literature is that obese
individuals have reduced maximum muscle strength
relative to body mass in their anti-gravity muscles
compared to non-obese persons (Abdelmoula et al.
2012; Blimkie et al. 1990; Hulens et al. 2001; Lafortuna
et al. 2005; Maffiuletti et al. 2007, 2008; Rolland et al.
2004; Delmonico et al. 2009). This effect on an obese
individual is shown to increase the risk of developing
osteoarthritis (Slemenda et al. 1998) and potentially
cause functional limitations especially in the elderly
(Visser et al. 2005). Evidence suggests that high levels
of adipositymay impair agonist muscle activation in the
young (Tomlinson et al. 2014a), adding to or perhaps
leading to the functional limitation of low strength
relative to body mass.
Future research is needed to systematically inves-
tigate whether body fat percentage per se may be
related to agonist muscle activation (using the inter-
polated twitch technique) and antagonist co-activation
(using surface electromyography) and/or morpholog-
ical characteristics, such as muscle volume, PCSA and
architecture (using gold standard techniques such
MRI, computed tomography and ultrasound imaging)
in the elderly focusing on individuals who are
classified sarcopenic obese. Interestingly within this
age classification, there appears to be a lack of
longitudinal studies examining how physical/seden-
tary activity across the age span impacts upon the
aforementioned variables.When examining the design
of future work, classification of obesity should be
made by adiposity (using DEXA) instead of
classification by individuals BMI and classification
of sarcopenia by the appendicular skeletal muscle
mass index. Key also, is to determine the impact of
duration of obesity, on the reported musculo-skeletal
structural and functional characteristics presented
during the study. Such knowledge would aid in the
development of therapeutic targets.
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